Chemotherapy: Open Access
Open Access

High Impact List of Articles

• Body Weight and Hematological Parameter Change in Advanced Breast Cancer Following Adjuvant Chemotherapy
  Mohamad Luthfi, Indra Wijaya and Heri Fadjari

  Research Article: Chemotherapy: Open Access

• Prediction Role of Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients Received the Neoadjuvant Chemotherapy: A Meta-Analysis
  Long Tao Tan, Jian Liu, Kai Cheng, Xiao Hong Wang, Ying Zhe Zhang, Xiao fei Teng and Zhen Lin Yang

  Research Article: Chemotherapy: Open Access

• Is Circulating Tumor DNA (Ctdna) Use Ready For Prime Time? Applications and Challenges of Ctdna in the Era of Precision Oncology
  Davis AA, Chae YK and Giles FJ

  Short Communication: Chemotherapy: Open Access

• Potential Spread of Methicillin-Resistant Staphylococcus aureus Recovered from Patients with Bloodstream Infection
  Renata MF Gomes, Maria Rosa Q Bomfim, Mariana JV Trindade, Luiz M Farias, Maria Auxiliadora R Carvalho, José Carlos Serufo and Simone G Santos

  Research Article: Chemotherapy: Open Access

• Targeting of HER Family Signaling Pathways in Gastric Cancer
  Bennal Perkins and Jennifer Wu

  Editorial: Chemotherapy: Open Access

Conference Proceedings

• Expression of the Human Papilloma Virus (HPV): Comparative assessment in peripheral blood and retinoblastomas
  Maria Tereza Cartaxo Muniz

  Posters-Accepted Abstracts: Chemotherapy: Open Access

• Fuse binding protein1 (FBP1) as antagonist of p53: A potential host target for drug development
  Virendra N Pandey

  Posters-Accepted Abstracts: Chemotherapy: Open Access

• Some HIV protease inhibitors have also other beneficial, non-virological effects with potential therapeutic applications
  Maude Loignon and Emil Toma

  Scientific Tracks Abstracts: Chemotherapy: Open Access

• Identification of miR-29c/FBXO31 as a key regulatory mechanism in esophageal cancer chemoresistance
  Bin Li, Wen Wen Xu, Jia Liu and Annie L M Cheung

  Scientific Tracks Abstracts: Chemotherapy: Open Access

• Clindamycin & Primaquine for Pneumocystis jirovecii pneumonia; 27 years after
  Emil Toma and Maude Loignon

  Scientific Tracks Abstracts: Chemotherapy: Open Access

Relevant Topics in Medical Sciences